Correction/mutation of acid α-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies

[1]  J. Smeitink,et al.  Enzyme therapy for Pompe disease with recombinant human α-glucosidase from rabbit milk , 2001, Journal of Inherited Metabolic Disease.

[2]  M. Tan,et al.  Expression of a Functional Asialoglycoprotein Receptor in Human Renal Proximal Tubular Epithelial Cells , 2002, Nephron.

[3]  M. Eller,et al.  DNA oligonucleotide treatment corrects the age‐associated decline in DNA repair capacity , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Rice,et al.  In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. , 2001, Nucleic acids research.

[5]  E. Kmiec,et al.  Targeted Gene Repair in Mammalian Cells Using Chimeric RNA/DNA Oligonucleotides and Modified Single-Stranded Vectors , 2001, Science's STKE.

[6]  O. Igoucheva,et al.  Targeted gene correction by small single-stranded oligonucleotides in mammalian cells , 2001, Gene Therapy.

[7]  J. Smeitink,et al.  Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. , 2001, Journal of inherited metabolic disease.

[8]  S. Tsujino,et al.  [Acid maltase deficiency]. , 2001, Ryoikibetsu shokogun shirizu.

[9]  J. Charrow,et al.  Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial , 2001, Genetics in Medicine.

[10]  A. Vulto,et al.  Recombinant human α-glucosidase from rabbit milk in Pompe patients , 2000, The Lancet.

[11]  Shui-Tein Chen,et al.  Facile Solid Phase Synthesis of YEE(ah-GalNAc)3, a Ligand with Known High Affinity for the Asialoglycoprotein Receptor , 2000 .

[12]  A. Reuser,et al.  Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. , 2000, Lancet.

[13]  N. Raben,et al.  Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Metzl,et al.  An Interesting Case of Infant Sudden Death: Severe Hypertrophic Cardiomyopathy in Pompe's Disease , 1999, Pacing and clinical electrophysiology : PACE.

[15]  A. Amalfitano,et al.  Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice. , 1999, Human gene therapy.

[16]  A. Kahn,et al.  Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. , 1998, Human molecular genetics.

[17]  J. V. Van Hove,et al.  Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts. , 1998, Pediatric research.

[18]  J. Shieh,et al.  Molecular study on the infantile form of Pompe disease in Chinese in Taiwan. , 1996, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui.

[19]  J. Levis,et al.  Cell-type specific and ligand specific enhancement of cellular uptake of oligodeoxynucleoside methylphosphonates covalently linked with a neoglycopeptide, YEE(ah-GalNAc)3. , 1995, Bioconjugate chemistry.

[20]  K. Zatloukal,et al.  Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. , 1992, Bioconjugate chemistry.

[21]  F. Sherman,et al.  Strand-specificity in the transformation of yeast with synthetic oligonucleotides. , 1992, Genetics.

[22]  M. Spiess,et al.  Asialoglycoprotein receptor. , 1992, International review of cytology.

[23]  F. Sherman,et al.  Transformation of yeast with synthetic oligonucleotides. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Hsiao,et al.  Study of alpha-D-glucosidase activity in patients with Pompe's disease. , 1986, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[25]  J. Martín,et al.  Identification of heterozygotes for glycogenosis 2 (Acid maltase deficiency) , 1981, Clinical genetics.

[26]  P. Gillette,et al.  Electrophysiological mechanism of the short PR interval in Pompe disease. , 1974, American journal of diseases of children.

[27]  H. Nadler,et al.  Alpha-1,4 glucosidase activity in Pompe's disease. , 1971, The Journal of pediatrics.

[28]  H. Hers.  alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease). , 1963, The Biochemical journal.

[29]  H. Hers.  α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease) , 1963 .